While the majority of Australians support the use of animals in research, this support is highly conditional and most agree there needs to be more transparency.
Laboratory accessories have enabled great strides for the life sciences industry, including new developments in drug discovery.
DHL has published a white paper on delivering stable logistics for vaccines and medical goods during COVID-19 and future health crises.
Australia's research workforce will be severely impacted by the COVID-19 pandemic for an extended period, according to a newly published report.
According to Afnan Zafar, collaboration in the field of product development must follow a strict set of rules if firms really want to benefit from open innovation and boost their performance.
A new analysis of more than 65 million papers, patents and software projects found that smaller teams produce much more disruptive and innovative research than larger teams.
The Australian Government's Science, Research and Innovation (SRI) Budget Tables show that overall investment in research and development is continuing to fall.
The USA's targeting of so-called 'foreign free-riding' in trade deals could lead to a poor deal on pharmaceuticals for the UK post-Brexit.
Gene therapies stand to benefit patients immensely, but there are questions about their commercial viability for pharmaceutical companies.
Although some malicious applications of synthetic biology may not seem plausible right now, they could become achievable with future advances.
A national survey has revealed that female scientists are not getting the same opportunities for promotion or seniority as their male peers with similar qualifications and experience.
Australia's future is at risk as performance declines amongst our maths and science students, says Science & Technology Australia (STA).
A new report has revealed favourable insights into clinical trials in Australia, where more than $1 billion is invested each year by both government and industry.
The overall market value of in vitro diagnostics stands at US$52 billion this year and is projected to grow at a compound annual growth rate of 4.2% to US$69 billion in 2024, according to GlobalData.
More than half (60%) of antibiotics given to patients after surgery to prevent infections are prescribed inappropriately, usually because they are not required at all — a situation that may be contributing to the rise of antibiotic resistance.